Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

Status unconfirmed · Phase 1

Conditions studied: Type1 Diabetes Mellitus, Type2 Diabetes Mellitus

In brief

This is a phase 1 multiple ascending dose (MAD) study, conducted in subjects with Type 1 and Type 2 diabetes mellitus

Key facts

Study ID

NCT03332849

Run by

Hanmi Pharmaceutical Company Limited

People needed

60

Starts

2015-07-28

Expected to finish

2018-04-30

Last updated by the study team

2017-11-06

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• T1DM or T2DM
• Female subjects must be non-pregnant and non-lactating

You may not qualify if…

• Pregnant or lactating women
• Participation in an investigational study within 30 days prior to dosing

Where it is running

• Hanmi Investigative Site — Chula Vista, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.